Kolominsky-Rabas PL - Search Results

1

The Evaluation of Economic Methods to Assess the Social Value of Medical Interventions for Ultra-Rare Disorders (URDS).

Schlander M, Garattini S, Holm S, Kolominsky-Rabas PL, Nord E, Persson U, Postma MJ, Richardson J, Simoens S, de Sola-Morales O, Tolley K, Toumi M. Schlander M, et al. Value Health. 2014 Nov;17(7):A324. doi: 10.1016/j.jval.2014.08.570. Epub 2014 Oct 26. Value Health. 2014. PMID: 27200532 Free article. No abstract available.

2

Determining the value of medical technologies to treat ultra-rare disorders: a consensus statement.

Schlander M, Garattini S, Kolominsky-Rabas P, Nord E, Persson U, Postma M, Richardson J, Simoens S, de Solà-Morales O, Tolley K, Toumi M. Schlander M, et al. J Mark Access Health Policy. 2016 Oct 27;4. doi: 10.3402/jmahp.v4.33039. eCollection 2016. J Mark Access Health Policy. 2016. PMID: 27857828 Free PMC article.

3

Incremental cost per quality-adjusted life year gained? The need for alternative methods to evaluate medical interventions for ultra-rare disorders.

Schlander M, Garattini S, Holm S, Kolominsky-Rabas P, Nord E, Persson U, Postma M, Richardson J, Simoens S, de Solà Morales O, Tolley K, Toumi M. Schlander M, et al. J Comp Eff Res. 2014 Jul;3(4):399-422. doi: 10.2217/cer.14.34. J Comp Eff Res. 2014. PMID: 25275236 Free article.

4

Determining Value in Health Technology Assessment: Stay the Course or Tack Away?

Caro JJ, Brazier JE, Karnon J, Kolominsky-Rabas P, McGuire AJ, Nord E, Schlander M. Caro JJ, et al. Pharmacoeconomics. 2019 Mar;37(3):293-299. doi: 10.1007/s40273-018-0742-2. Pharmacoeconomics. 2019. PMID: 30414074 Free PMC article.

5

The efficiency frontier approach to economic evaluation of health-care interventions.

Caro JJ, Nord E, Siebert U, McGuire A, McGregor M, Henry D, de Pouvourville G, Atella V, Kolominsky-Rabas P. Caro JJ, et al. Health Econ. 2010 Oct;19(10):1117-27. doi: 10.1002/hec.1629. Health Econ. 2010. PMID: 20575151

6

The Health Economic Impact of Resource use in Dementia: the Erlanger Dementia Registry (EDR).

Schaller SU, Marinova-Schmidt V, Gobin J, Luttenberger K, Richter-Schmidinger T, Gräßel E, Maler JM, Kornhuber J, Kolominsky-Rabas PL. Schaller SU, et al. Value Health. 2014 Nov;17(7):A465. doi: 10.1016/j.jval.2014.08.1299. Epub 2014 Oct 26. Value Health. 2014. PMID: 27201316 Free article. No abstract available.

7

Accessing the Medical Device Market in the People's Republic of China--Policy Changes Since the Restructuring of the China Fda.

Zhang SX, Kriza C, Kolominsky-Rabas PL. Zhang SX, et al. Value Health. 2014 Nov;17(7):A414-5. doi: 10.1016/j.jval.2014.08.998. Epub 2014 Oct 26. Value Health. 2014. PMID: 27201027 Free article. No abstract available.

8

A Systematic Review Of Cost-Of-Illness Studies In Chronic Heart Failure.

Lesyuk W, Kriza C, Kolominsky-Rabas PL. Lesyuk W, et al. Value Health. 2014 Nov;17(7):A484. doi: 10.1016/j.jval.2014.08.1411. Epub 2014 Oct 26. Value Health. 2014. PMID: 27201423 Free article. No abstract available.

9

Analysis of Cardiac Implants Recalls in the Last Decade: An International Comparison.

Zhang SX, Kriza C, Schaller SU, Kolominsky-Rabas PL. Zhang SX, et al. Value Health. 2014 Nov;17(7):A499. doi: 10.1016/j.jval.2014.08.1497. Epub 2014 Oct 26. Value Health. 2014. PMID: 27201504 Free article. No abstract available.

10

The Hanover Consensus: helpful for German decision-makers?

Kolominsky-Rabas PL, Caro JJ. Kolominsky-Rabas PL, et al. Value Health. 2008 Jul-Aug;11(4):545-6; discussion 547-8. doi: 10.1111/j.1524-4733.2008.00318.x. Epub 2008 May 16. Value Health. 2008. PMID: 18489522 Free article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

111 results

Search Page

Filters